Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the US

/PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty S.A., a subsidiary of Glenmark...

Related Keywords

India ,United States ,Dubai ,Dubayy ,United Arab Emirates ,Mumbai ,Maharashtra ,United Kingdom ,London ,City Of ,Americans ,Steve Weiss ,Leonard Bielory ,Susan Ringdal ,David Belian ,Udaykumar Murthy ,Brian Hoffmann ,Brendan Ogrady ,Instagram ,Moody ,Global Affairs ,Hikma Pharmaceuticals United States Inc ,Public Affairs ,Drug Administration ,Hackensack Meridian School Of Medicine ,Linkedin Glenmark Pharmaceuticals ,Glenmark Pharmaceuticals ,National Institute For Health ,Us Communications ,Prnewswire Hikma Pharmaceuticals ,Corporate Communications ,Biosimilars Companies ,Glenmark Pharmaceuticals Ltd ,Hikma Pharmaceuticals ,Hackensack Meridian School ,Brendano Grady ,Chief Executive Officer ,Formulations Business ,Seasonal Allergic ,United Sates ,Strategic Planning ,Middle East ,North Africa ,Pharmaceutical Sales ,Dow Jones Sustainability Index ,Social Media ,Safety Information ,Allergy Asthma ,Allergy Clin North ,Allergy Clin ,Pacj Allergy ,Head Neck ,Biologic Therapies ,Asthma Associated ,Acquisition Costs ,Allergy Clin Immunol ,Pharmaceuticals United States ,Hikma Pharmaceuticals Usa Inc ,